Compare VNRX & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VNRX | ATCH |
|---|---|---|
| Founded | N/A | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 34.9M |
| IPO Year | 2012 | 2024 |
| Metric | VNRX | ATCH |
|---|---|---|
| Price | $0.20 | $0.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | 1.9M | ★ 4.2M |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $1,233,511.00 | N/A |
| Revenue This Year | $60.84 | N/A |
| Revenue Next Year | $404.89 | N/A |
| P/E Ratio | ★ N/A | $3.91 |
| Revenue Growth | ★ 59.10 | N/A |
| 52 Week Low | $0.17 | $0.14 |
| 52 Week High | $0.94 | $2.09 |
| Indicator | VNRX | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 38.77 | 38.29 |
| Support Level | N/A | $0.22 |
| Resistance Level | $0.33 | $0.24 |
| Average True Range (ATR) | 0.03 | 0.02 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 28.48 | 12.91 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.